April 2021 Simoa® Publications:
Neurology: General
Investigating the Presence of Interattack Astrocyte Damage in Neuromyelitis Optica Spectrum Disorder: Longitudinal Analysis of Serum Glial Fibrillary Acidic Protein
Hyun JW, et al.
Neurology® Neuroimmunology & Neuroinflammation. 2021;8
Ibudilast (MN-166) in Amyotrophic Lateral Sclerosis- An Open Label, Safety And Pharmacodynamic Trial
Babu S, et al.
NeuroImage: Clinical. 2021:102672
Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration
Rojas JC, et al.
Neurology. 2021
Association of serum neurofilament light chain levels with clinicopathology of chronic inflammatory demyelinating polyneuropathy, including NF155 reactive patients
Fukami Y, et al.
Journal of Neurology. 2021
Genetic inactivation of RIP1 kinase activity in rats protects against ischemic brain injury
Stark K, et al.
Cell Death & Disease. 2021;12:379
Blood biomarkers for dementia in Hispanic and non-Hispanic White adults
Gonzales MM, et al.
Alzheimers Dement (N Y). 2021;7:e12164
A longitudinal analysis of brain extracellular free water in HIV infected individuals
Uddin MN, et al.
Sci Rep. 2021;11:8273
Neurofilament light chain: A novel blood biomarker in patients with ataxia telangiectasia
Veenhuis SJG, et al.
European Journal of Paediatric Neurology. 2021;32:93-97
Diagnostic and prognostic value of plasma neurofilament light and total-tau in sporadic Creutzfeldt-Jakob disease
Zerr I, et al.
Alzheimers Res Ther. 2021;13:86
TREM2 expression in the brain and biological fluids in prion diseases.
Diaz-Lucena D, et al.
Acta Neuropathologica. 2021
The pattern of inflammatory markers during electroconvulsive therapy in older depressed patients
Carlier A, et al.
World J Biol Psychiatry. 2021:1-24
April 2021 Simoa® Publications in Other Therapeutic Areas
